Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Warner

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
American Journal of Clinical Oncology|June 6, 2008
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patientsAndrew S Kennedy, William A Dezarn, Patrick McNeillie, et al.
Journal of Gastrointestinal Cancer|March 9, 2020
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid SyndromeJoseph S Dillon, Matthew H Kulke, Dieter Hörsch, et al.
The Oncologist|January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid SyndromeLowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Endocrine-Related Cancer|January 14, 2018
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trialMarianne Pavel, David J Gross, Marta Benavent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid SyndromeMatthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
JB & JS Open Access|April 30, 2024
Five-Year Mortality Rates Following Elective Shoulder Arthroplasty and Shoulder Arthroplasty for Fracture in Patients Over Age 65Adam Z Khan, Xiaoran Zhang, Erlyn Macarayan, et al.
Clinical Orthopaedics and Related Research|February 28, 2023
Higher Surgeon Volume is Associated With a Lower Rate of Subsequent Revision Procedures After Total Shoulder Arthroplasty: A National AnalysisMatthew J Best, Catherine J Fedorka, Derek A Haas, et al.
JBJS Reviews|August 22, 2024
Utility of Machine Learning, Natural Language Processing, and Artificial Intelligence in Predicting Hospital Readmissions After Orthopaedic Surgery: A Systematic Review and Meta-AnalysisMohamad Y Fares, Harry H Liu, Ana Paula Beck da Silva Etges, et al.
JSES International|November 21, 2022
The impact of the COVID-19 pandemic on racial disparities in patients undergoing total shoulder arthroplasty in the United States, Matthew J Best, Catherine J Fedorka, et al.
Journal of Shoulder and Elbow Surgery|September 8, 2022
Impact of the COVID-19 pandemic on shoulder arthroplasty: surgical trends and postoperative care pathway analysis, Adam Z Khan, Matthew J Best, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
American Journal of Clinical Oncology|June 6, 2008
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patientsAndrew S Kennedy, William A Dezarn, Patrick McNeillie, et al.
Journal of Gastrointestinal Cancer|March 9, 2020
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid SyndromeJoseph S Dillon, Matthew H Kulke, Dieter Hörsch, et al.
The Oncologist|January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid SyndromeLowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Endocrine-Related Cancer|January 14, 2018
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trialMarianne Pavel, David J Gross, Marta Benavent, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid SyndromeMatthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
JB & JS Open Access|April 30, 2024
Five-Year Mortality Rates Following Elective Shoulder Arthroplasty and Shoulder Arthroplasty for Fracture in Patients Over Age 65Adam Z Khan, Xiaoran Zhang, Erlyn Macarayan, et al.
Clinical Orthopaedics and Related Research|February 28, 2023
Higher Surgeon Volume is Associated With a Lower Rate of Subsequent Revision Procedures After Total Shoulder Arthroplasty: A National AnalysisMatthew J Best, Catherine J Fedorka, Derek A Haas, et al.
JBJS Reviews|August 22, 2024
Utility of Machine Learning, Natural Language Processing, and Artificial Intelligence in Predicting Hospital Readmissions After Orthopaedic Surgery: A Systematic Review and Meta-AnalysisMohamad Y Fares, Harry H Liu, Ana Paula Beck da Silva Etges, et al.
JSES International|November 21, 2022
The impact of the COVID-19 pandemic on racial disparities in patients undergoing total shoulder arthroplasty in the United States, Matthew J Best, Catherine J Fedorka, et al.
Journal of Shoulder and Elbow Surgery|September 8, 2022
Impact of the COVID-19 pandemic on shoulder arthroplasty: surgical trends and postoperative care pathway analysis, Adam Z Khan, Matthew J Best, et al.
Pageof 41